Page 53 - AN-1-3

Advanced Neurology The diagnosis and treatment of anti-LGI1 autoimmune encephalitis

Behav, 10: 529–538. topography of autoimmune non-paraneoplastic encephalitis.
Neuroradiology, 60: 189–198.
https://doi.org/10.1016/j.yebeh.2007.03.011
https://doi.org/10.1007/s00234-017-1956-2
51. Lai M, Huijbers MG, Lancaster E, et al., 2010, Investigation
of LGI1 as the antigen in limbic encephalitis previously 62. Morano A, Fanella M, Irelli EC, et al., 2020, Seizures in
attributed to potassium channels: A case series. Lancet autoimmune encephalitis: Findings from an EEG pooled
Neurol, 9(8): 776–785. analysis. Seizure, 83: 160–168.
https://doi.org/10.1016/S1474-4422(10)70137-X https://doi.org/10.1016/j.seizure.2020.10.019
52. Tofaris GK, Irani SR, Cheeran BJ, et al., 2012, 63. Baumgartner T, Pitsch J, Olaciregui-Dague K, et al., 2022,
Immunotherapy-responsive chorea as the presenting feature Seizure underreporting in LGI1 and CASPR2 antibody
of LGI1-antibody encephalitis. Neurology, 79: 195–196. encephalitis. Epilepsia, 63: e100–e105.
https://doi.org/10.1212/WNL.0b013e31825f0522 https://doi.org/10.1111/epi.17338
53. Balint B, Vincent A, Meinck HM, et al., 2018, Movement 64. Zhong R, Chen Q, Zhang X, et al., 2022, Relapses of anti-
disorders with neuronal antibodies: Syndromic approach, NMDAR, anti-GABABR and anti-LGI1 encephalitis:
genetic parallels and pathophysiology. Brain, 141: 13–36. A retrospective cohort study. Front Immunol, 13: 918396.
https://doi.org/10.1093/brain/awx189 https://doi.org/10.3389/fimmu.2022.918396
54. Gadoth A, Pittock SJ, Dubey D, et al., 2017, Expanded 65. Irani SR, Pettingill P, Kleopa KA, et al., 2012, Morvan
phenotypes and outcomes among 256 LGI1/CASPR2-IgG- syndrome: Clinical and serological observations in 29 cases.
positive patients. Ann Neurol, 82: 79–92. Ann Neurol, 72: 241–255.
https://doi.org/10.1002/ana.24979 https://doi.org/10.1002/ana.23577
55. Jang Y, Lee ST, Lim JA, et al., 2018, Psychiatric symptoms delay 66. Irani SR, Alexander S, Waters P, et al., 2010, Antibodies
the diagnosis of anti-LGI1 encephalitis. J Neuroimmunol, to Kv1 potassium channel-complex proteins leucine-rich,
317: 08–14. glioma inactivated 1 protein and contactin-associated
protein-2 in limbic encephalitis, Morvan’s syndrome and
https://doi.org/10.1016/j.jneuroim.2018.02.005
acquired neuromyotonia. Brain, 133: 2734–2748.
56. Peter-Derex L, Devic P, Rogemond V, et al., 2012, Full
recovery of agrypnia associated with anti-Lgi1 antibodies https://doi.org/10.1093/brain/awq213
encephalitis under immunomodulatory treatment: A case 67. Titulaer MJ, Soffietti R, Dalmau J, et al., 2011, Screening for
report with sequential polysomnographic assessment. Sleep tumours in paraneoplastic syndromes: Report of an EFNS
Med, 13: 554–556. task force. Eur J Neurol, 18: 19–e3.
https://doi.org/10.1016/j.sleep.2012.01.002 https://doi.org/10.1111/j.1468-1331.2010.03220.x
57. Jarius S, Hoffmann L, Clover L, et al., 2008, CSF findings 68. Maki Y, Takashima H, 2016, Clinical features and treatment
in patients with voltage gated potassium channel antibody of hashimoto encephalopathy. Brain Nerve, 68: 1025–1033.
associated limbic encephalitis. J Neurol Sci, 268: 74–77.
https://doi.org/10.11477/mf.1416200549
https://doi.org/10.1016/j.jns.2007.11.004
69. Huang X., Fan C, Gao L, et al., 2022, Clinical features,
58. Li Y, Song F, Liu W, et al., 2021, Clinical features of nine immunotherapy, and outcomes of anti-leucine-rich glioma-
cases of leucine-rich glioma inactivated 1 protein antibody- inactivated-1 encephalitis. J Neuropsychiatry Clin Neurosci,
associated encephalitis. Acta Neurol Belg, 121: 889–897. 34: 141–148.
https://doi.org/10.1007/s13760-020-01336-z https://doi.org/10.1176/appi.neuropsych.20120303
59. Wang M, Cao X, Liu Q, et al., 2017, Clinical features of 70. Galeotti C, Kaveri SV, Bayry J, et al., 2017, IVIG-mediated
limbic encephalitis with LGI1 antibody. Neuropsychiatr Dis effector functions in autoimmune and inflammatory
Treat, 13: 1589–1596. diseases. Int Immunol, 29: 491–498.
https://doi.org/10.2147/NDT.S136723 https://doi.org/10.1093/intimm/dxx039
60. Rissanen E, Carter K, Cicero S, et al., 2022, Cortical and 71. Rodriguez A, Klein CJ, Sechi E, et al., 2022, LGI1 antibody
subcortical dysmetabolism are dynamic markers of clinical encephalitis: Acute treatment comparisons and outcome.
disability and course in anti-LGI1 encephalitis. Neurol J Neurol Neurosurg Psychiatry, 93: 309–315.
Neuroimmunol Neuroinflamm, 9: e1136.
https://doi.org/10.1136/jnnp-2021-327302
https://doi.org/10.1212/NXI.0000000000001136
72. Zhang Y, Huang HJ, Chen WB, et al., 2021, Clinical
61. Tripathi M, Tripathi M, Roy SG, et al., 2018, Metabolic efficacy of plasma exchange in patients with autoimmune

Volume 1 Issue 3 (2022) 10 https://doi.org/10.36922/an.v1i3.237